Related Experiment Videos

Perindopril, atenolol, and amlodipine prevent aortic ultrastructural changes in rats exposed to ethanol

Mehmet Yokusoglu1, Cemal Sag, Mehmet Cincik

  • 1Department of Cardiology, Gulhane Military Medical School, Etlik, Ankara, Turkey. myokusoglu@gata.edu.tr

Abstract

Insights

High doses of perindopril, atenolol, and amlodipine showed protective effects against alcohol-induced aortic wall injury in rats. These findings suggest potential therapeutic benefits for heavy chronic alcohol consumption.

Area of Science:

  • Cardiovascular Pharmacology
  • Toxicology
  • Drug Efficacy Studies

Background:

  • Chronic alcohol consumption can lead to significant cardiovascular damage, particularly affecting the aorta.
  • Investigating the protective effects of common cardiovascular drugs against alcohol-induced injury is crucial.

Purpose of the Study:

  • To evaluate the potential protective effects of perindopril, atenolol, and amlodipine against chronic alcohol-induced aortic wall injury in rats.
  • To determine the dose-dependent efficacy of these drugs in mitigating alcohol-related vascular damage.

Main Methods:

  • Adult male Wistar rats were administered alcohol via a modified liquid diet for 21 days.
  • Perindopril, atenolol, and amlodipine were administered intraperitoneally at varying doses.
  • Aortic tissue was examined using transmission electron microscopy, and blood alcohol levels were measured.

Main Results:

  • Chronic alcohol consumption resulted in notable aortic wall injuries in rats.
  • High doses of perindopril, atenolol, and amlodipine demonstrated significant beneficial effects on alcohol-induced aortic damage.
  • Low doses of these drugs did not produce significant protective effects.

Conclusions:

  • Perindopril, atenolol, and amlodipine, particularly at high doses, may offer protective effects against aortic wall injury induced by heavy chronic alcohol consumption.
  • These findings highlight the potential therapeutic role of these drugs in managing alcohol-related cardiovascular complications.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...